Ocugen GA Trial Advances Toward Phase 3
May 1, 2026
Ocugen reports positive Phase 2 data for its OCU410 gene therapy in geographic atrophy
1 min read
False
Advertisement
May
Bridging the Diabetic Eye Care Divide
May 1, 2026
Study evaluates eye care utilization of diabetic patients in Northern Uganda, spotlighting limited health literacy and awareness as determining factors in care
3 min read
GA Gene Therapy Interest Increases
May 1, 2026
Phase I trial results of PulseSight Therapeutics’ PST-611 to be presented at ARVO 2026
2 min read
Browse by Subspecialties
False
Advertisement